Loading…

Prognostic significance of pronormoblasts in erythrocyte predominant myelodysplastic patients

Recent studies of acute erythroleukemias have reaffirmed DiGuglielmo's syndrome (M6a, myeloblast‐predominant) and disease (M6b, pronormoblast‐predominant). M6c (mixed myeloblast/pronormoblast) has also been described. However, MDS is still defined according to the percentage of myeloblasts (% m...

Full description

Saved in:
Bibliographic Details
Published in:American journal of hematology 2006-07, Vol.81 (7), p.484-491
Main Authors: Mazzella, Fermina M., Smith, David, Horn, Paul, Cotelingam, James D., Rector, James T., Shrit, M. Atef, Pesce, Amadeo, Schumacher, Harold R.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Recent studies of acute erythroleukemias have reaffirmed DiGuglielmo's syndrome (M6a, myeloblast‐predominant) and disease (M6b, pronormoblast‐predominant). M6c (mixed myeloblast/pronormoblast) has also been described. However, MDS is still defined according to the percentage of myeloblasts (% myeloblasts) without including the pronormoblast count. A 20‐year retrospective study was performed to identify cases demonstrating ≥50% erythrocytic component and
ISSN:0361-8609
1096-8652
DOI:10.1002/ajh.20563